Evidence map›Paper›PMID 25701550›Full record

ReviewBiochimie2015

Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins.

Eileen Chen, Simpson Joseph

Abstract readReview
In one paragraph

Review in Biochimie, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Cells · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. The RGG motif proteins: Interactions, functions, and regulations.Wiley interdisciplinary reviews. RNA · 2023
    Review
  10. Article
  11. FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. RNA-binding proteins in human genetic disease.Nature reviews. Genetics · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eileen ChenDepartment of Chemistry and Biochemistry, University of California at San Diego 9500 Gilman Drive, La Jolla, CA 92093-0314, USA.
Simpson JosephDepartment of Chemistry and Biochemistry, University of California at San Diego 9500 Gilman Drive, La Jolla, CA 92093-0314, USA. Electronic address: sjoseph@ucsd.edu.
University of California, San Diego · US

Funding

MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
Molecular Role of 16S Ribosomal RNA in TranslocationR01GM065265 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOSEPH, SIMPSON · 2002 to 2011
$2.5M
NIGMS NIH HHS GM08326NIGMS NIH HHS R01 GM065265NIGMS NIH HHS T32 GM008326
6 · The paper itself

Abstract

Translational control is a common mechanism used to regulate gene expression and occur in bacteria to mammals. Typically in translational control, an RNA-binding protein binds to a unique sequence in the mRNA to regulate protein synthesis by the ribosomes. Alternatively, a protein may bind to or modify a translation factor to globally regulate protein synthesis by the cell. Here, we review translational control by the fragile X mental retardation protein (FMRP), the absence of which causes the neurological disease, fragile X syndrome (FXS).

Indexed as

Protein BiosynthesisAnimalsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene Expression RegulationHumansMolecular Targeted TherapyRNA-Binding ProteinsFragile X Messenger Ribonucleoprotein 1RNA-Binding ProteinsFragile X mental retardation proteinFragile X syndromeNeuronRibosomeRNATranslation

Identifiers

PMID25701550
PMCPMC4458461
OpenAlexW2063792852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.